Chargement en cours...
Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination
BACKGROUND: Platelet derived growth factor is integral to maintenance of blood brain barrier, increases in response to blood brain barrier disruption, and may reflect neuroinflammation. Based on previous reports of better outcomes with dopaminergic antidepressants in depressed patients with elevated...
Enregistré dans:
| Publié dans: | Int J Neuropsychopharmacol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5737519/ https://ncbi.nlm.nih.gov/pubmed/29016822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyx060 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|